Applied Therapeutics Inc (NASDAQ: APLT) on Friday, soared 9.16% from the previous trading day, before settling in for the closing price of $0.59. Within the past 52 weeks, APLT’s price has moved between $0.54 and $10.62.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of 1.41%. With a float of $92.16 million, this company’s outstanding shares have now reached $116.36 million.
The firm has a total of 25 workers. Let’s measure their productivity. In terms of profitability, gross margin is 378.67%, operating margin of 43736.49%, and the pretax margin is 88772.51%.
Applied Therapeutics Inc (APLT) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Applied Therapeutics Inc is 21.33%, while institutional ownership is 83.82%. The most recent insider transaction that took place on Feb 06 ’25, was worth 14,000. In this transaction an insider of this company sold 22,950 shares at a rate of $0.61, taking the stock ownership to the 404,961 shares. Before that another transaction happened on Feb 06 ’25, when Company’s Chief Medical Officer sold 86,078 for $0.61, making the entire transaction worth $52,508. This insider now owns 900,775 shares in total.
Applied Therapeutics Inc (APLT) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.16 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 1.41% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 41.84% during the next five years compared to -8.72% drop over the previous five years of trading.
Applied Therapeutics Inc (NASDAQ: APLT) Trading Performance Indicators
Applied Therapeutics Inc (APLT) is currently performing well based on its current performance indicators. A quick ratio of 1.06 was reported for the most recent quarter.
Technical Analysis of Applied Therapeutics Inc (APLT)
Analysing the last 5-days average volume posted by the [Applied Therapeutics Inc, APLT], we can find that recorded value of 2.91 million was lower than the volume posted last year of 5.0 million. As of the previous 9 days, the stock’s Stochastic %D was 42.73%. Additionally, its Average True Range was 0.10.
During the past 100 days, Applied Therapeutics Inc’s (APLT) raw stochastic average was set at 1.07%, which indicates a significant decrease from 81.32% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 85.38% in the past 14 days, which was lower than the 241.20% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.8298, while its 200-day Moving Average is $4.9399. Now, the first resistance to watch is $0.6826. This is followed by the second major resistance level at $0.7181. The third major resistance level sits at $0.7644. If the price goes on to break the first support level at $0.6008, it is likely to go to the next support level at $0.5545. Should the price break the second support level, the third support level stands at $0.5190.
Applied Therapeutics Inc (NASDAQ: APLT) Key Stats
Market capitalization of the company is 75.28 million based on 116,356K outstanding shares. Right now, sales total 9,990 K and income totals -119,760 K. The company made 120 K in profit during its latest quarter, and -68,590 K in sales during its previous quarter.
